Ashleigh Palmer is the founder of Provention Bio. Provention Bio has raised $28M in total funding. Latest round: Series A.
Ashleigh Palmer is a co-founder and CEO of Provention Bio, a clinical-stage biopharmaceutical company focused on developing therapeutics for immune-mediated diseases. The company secured $28.4 million in founding financing to advance its mission of early disease interception and prevention.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide